Get the Stockscreener App
0.239
13.72%
-0.038
Intensity Therapeutics Inc stock is traded at $0.239, with a volume of 9.33M.
It is down -13.72% in the last 24 hours and down -22.45% over the past month.
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
See More
Previous Close:
$0.277
Open:
$0.2742
24h Volume:
9.33M
Relative Volume:
3.27
Market Cap:
$6.23M
Revenue:
-
Net Income/Loss:
$-16.26M
P/E Ratio:
-0.2023
EPS:
-1.1814
Net Cash Flow:
$-13.50M
1W Performance:
-26.46%
1M Performance:
-22.45%
6M Performance:
-89.19%
1Y Performance:
-95.06%
1-Day Range:
$0.1853
$0.275
1-Week Range:
$0.1853
$0.36
52-Week Range:
$0.1853
$4.9299
Intensity Therapeutics Inc Stock (INTS) Company Profile
Name
Intensity Therapeutics Inc
Sector
Industry
Phone
203-221-7381
Address
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Compare INTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INTS
Intensity Therapeutics Inc
|
0.239 | 7.22M | 0 | -16.26M | -13.50M | -1.1814 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Intensity Therapeutics Inc Stock (INTS) Latest News
Is Intensity Therapeutics Inc. meeting your algorithmic filter criteriaROI Focused Setup Screener With Exit Markers - Newser
What is the dividend policy of Intensity Therapeutics Inc. stockAI Powered Ideas With High Returns - jammulinksnews.com
Technical signs of recovery in Intensity Therapeutics Inc.Real-Time Equity Price Action Analysis - Newser
Why Intensity Therapeutics Inc. stock attracts strong analyst attentionSmart Stock Forecast Using AI Algorithms - Newser
What is the risk reward ratio of investing in Intensity Therapeutics Inc. stockPost Market Updates For Consistent Profits - jammulinksnews.com
Does Intensity Therapeutics Inc. stock perform well during market downturnsPost Market Trend Scanner For Smart Trading - jammulinksnews.com
Regression analysis insights on Intensity Therapeutics Inc. performanceFree News Based Entry Opportunity Alerts - Newser
What makes Intensity Therapeutics Inc. stock price move sharplyShort Term Profit Strategy with Entry Cues - Newser
What are analysts’ price targets for Intensity Therapeutics Inc. in the next 12 monthsChart Pattern Strategy To Watch Now - jammulinksnews.com
How to recover losses in Intensity Therapeutics Inc. stockFree Low Risk Equity Screener With Results - Newser
How volatile is Intensity Therapeutics Inc. stock compared to the marketWealth Building Signals From AI Tools - jammulinksnews.com
Buy Signal for Intensity Therapeutics Inc. Stock Key Technical Indicators to WatchFree Chart Alert System With Entry Targets - Newser
Can swing trading help recover from Intensity Therapeutics Inc. lossesFree Secure Return Focused Investment Plan - Newser
Is Intensity Therapeutics Inc. still worth holding after the dipEarnings Report Summary with Market Impact - Newser
Intensity Therapeutics, Inc. (INTS) Receives a New Rating from ThinkEquity - The Globe and Mail
Intensity Therapeutics Inc. Volume Confirms Breakout — Analysts BullishLow Risk Buy Zone Opportunity Watch Ongoing - metal.it
Chartists Watching For Breakout in Intensity Therapeutics Inc.Reversal Alert Based on RSI Indicator Confirmed - metal.it
Will Intensity Therapeutics Inc. Reverse From Oversold ConditionsWealth Building Stock Market Ideas Based on Momentum - metal.it
What are the latest earnings results for Intensity Therapeutics Inc.Top Growth Signals From AI Tools - jammulinksnews.com
How strong is Intensity Therapeutics Inc. company’s balance sheetDiscover high-impact stocks for your portfolio - jammulinksnews.com
Applying big data sentiment scoring on IonQ Inc.Wealth Accumulation Outlook for Safe Investors - Newser
When is Intensity Therapeutics Inc. stock expected to show significant growthStay informed with daily expert analysis - jammulinksnews.com
What catalysts could drive Intensity Therapeutics Inc. stock higher in 2025Achieve unparalleled market performance - jammulinksnews.com
Is it the right time to buy Intensity Therapeutics Inc. stockBuild a winning investment strategy - jammulinksnews.com
What are Intensity Therapeutics Inc. company’s key revenue driversGet alerts on high-potential stock breakouts - jammulinksnews.com
Should I hold or sell Intensity Therapeutics Inc. stock in 2025Fast-track wealth growth - jammulinksnews.com
What are the technical indicators suggesting about Intensity Therapeutics Inc.Unlock exclusive stock market forecasts - jammulinksnews.com
How Resilient Is Intensity Therapeutics Inc. Stock During Economic DownturnsFree Access to Community - Newser
Intensity Therapeutics Inc Stock (INTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):